Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-200
Closed -$3K 814
2022
Q1
$3K Buy
+200
New +$13.7K ﹤0.01% 872

Other funds holding ACLS

Moors & Cabot's ACLS Position: Q1 2026 in Review

Moors & Cabot reduced its Axcelis (ACLS) stake by 43% in Q1 2026, selling an estimated $286K and leaving 4,200 shares worth $391K. The position accounts for 0.02% of the portfolio, ranked #617.

Moors & Cabot first reported a position in ACLS in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.88M in Q2 2023. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Moors & Cabot held 4,200 shares of Axcelis worth $391K as of Q1 2026.
  • Moors & Cabot sold 3,230 Axcelis shares in Q1 2026, an estimated $286K.
  • Axcelis made up 0.02% of Moors & Cabot's portfolio in Q1 2026, its #617 holding.
  • Moors & Cabot first reported a position in Axcelis in Q1 2021 and has held it in 21 quarters since.
  • Moors & Cabot's Axcelis position peaked at $1.88M in Q2 2023.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.